Lipoxin A 4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway.

Autor: Zhang T; Department of Pathophysiology, Medical College of Nanchang University, Nanchang, 330006, China., Hao H; Department of Pathology, Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China., Zhou ZQ; The First Clinical Medical College, Nanchang University, Nanchang, 330006, China., Zeng T; Medical college, Jingchu University of Technology, Jingmen, Hubei 448000, China., Zhang JM; Department of Pathophysiology, Medical College of Nanchang University, Nanchang, 330006, China., Zhou XY; Department of Pathophysiology, Medical College of Nanchang University, Nanchang, 330006, China; Jiangxi Province Key Laboratory of Tumor Etiology and Molecular Pathology, Nanchang, 330006, China. Electronic address: zhouxiaoyan@ncu.edu.cn.
Jazyk: angličtina
Zdroj: Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2020 Feb; Vol. 146, pp. 106380. Date of Electronic Publication: 2019 Nov 04.
DOI: 10.1016/j.prostaglandins.2019.106380
Abstrakt: Background: The deposition of extracellular matrix (ECM) during hepatic fibrosis is an intermediate process in the progression of multiple chronic liver diseases to cirrhosis. Because activated hepatic stellate cells (HSCs) are the main source of ECM, HSCs activation is the central link in the formation of liver fibrosis. It was reported that the analogs of lipoxin A 4 (LXA 4 ) had anti-fibrotic effects, but the mechanisms are still not clear. This study was conducted to explore the possible mechanisms involved in the process of LXA 4 -mediated inhibition of HSCs activation.
Methods: Rat HSC-T6 cells were activated by LPS and treated with LXA 4 and/or BOC-2. The levels of ECM were assessed by hydroxyproline (Hyp) kit. The protein levels of α-SMA, Collagen I and III, MMP-2, MMP-9, TGF-β1, PDGF A and B, NF-κB P65, phosphorylated NF-κB P65 (P-P65) and NF-κB inhibitor α (I-κBα) were measured via western blot. The mRNA levels of MMP-2 and MMP-9 were observed by real-time PCR. The contents of TGF-β1 and PDGF were assessed by ELISA kits. Nuclear transfer assay kit was used to assess the activation and translation of NF-κB P65.
Results: (1) LPS activated HSC-T6 cells and up-regulated α-SMA, but LXA 4 decreased LPS-induced α-SMA in HSC-T6 cells. (2) LXA 4 inhibited LPS-induced Hyp production, meanwhile down-regulated LPS-induced Collagen I, Collagen III, MMP-2, and MMP-9 in HSC-T6 cells. (3) LXA 4 decreased LPS-induced TGF-β1 and PDGF in HSC-T6 cells. (4) LXA 4 repressed LPS-activated NF-κB signaling pathway, causing a reduction of I-κBα degradation, NF-κB phosphorylation, and NF-κB p65 transposition in HSC-T6 cells. (4) BOC-2, the blocker of LXA 4 receptor, inhibited all the effects of LXA 4 .
Conclusion: LXA 4 inhibited HSCs activation through down-regulation TGF-β1/PDGF, and repression NF-κB signal pathway.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: